Research article · 26 Apr 2023
Research articlePublished 25 Sep 2022
The use of mean platelet volume mpv in differentiating between hyper destructive versus hypo productive thrombocytopenia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: To establish the use of the mean platelet volume (MPV) as a tool in distinguishing between the hyper destructive versus hypo productive causes of thrombocytopenia. Methods: This study was conducted at pathology department, Khawaja Muhammad Safdar Medical College, Sialkot (KMSMCS) from July 2020 to December 2020. Ethical approval was obtained from ethical committee of KMSMCS. 180 patients having platelet count less than 100x109/L were enrolled. Patients were categorized into two groups; A. Patients having thrombocytopenia due to increase destruction of platelets. B. Patients having thrombocytopenia due to reduced production of platelets. Patients were selected from the CBC print generated by the automated haematology analyzer. Platelet count was manually verified by examining peripheral blood smear (PBS) on glass slides. MPV was recorded from the haematology analyzer print. Results: 180 patients having platelet count less than 100x109 /L were enrolled. 87 were males and 93 were females. The male to female ratio was 1: 1.07. Age of the patients were between 0 - 88 years. Patients were further categorized into three groups on the basis of age. Group A (0 - 30 years), B (31 – 60 years) and C (61 -90 years). Group B wasthe most common age group having 108 patients followed by group A which had 42. Conclusion: MPV is a platelet parameter which is readily available, authentic and can be relied upon to help as regards the basic cause of thrombocytopenia. It is also more convenient for the patient as compared to the bone marrow examination.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutical Sciences and Drug Development.
Opinion · 22 Nov 2022
Fresher Advancements Drugs in the Nanoparticles for Malignant growth Treatment
Perspective · 20 Nov 2022
Evaluating of Ecliptic Alba Concentrates for Anticancer Movement
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Sciences and Drug Development
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Muhammad Faisal Bashir”
- BylineArticles whose byline prints “Sidra Ghazanfer”
- BylineArticles whose byline prints “Faiz Ahmed Faiz”
- BylineArticles whose byline prints “Sarah Rafi”
- BylineArticles whose byline prints “Hasan Osman Mahmoodf”
- BylineArticles whose byline prints “Khalid Aftab”
